Abstract:Mayaro virus (MAYV) is a mosquito-transmitted alphavirus that causes debilitating and persistent arthritogenic disease. While MAYV was previously reported to infect non-human primates (NHP), characterization of MAYV pathogenesis is currently lacking. Therefore, in this study we characterized MAYV infection and immunity in rhesus macaques. To inform the selection of a viral strain for NHP experiments, we evaluated five MAYV strains in C57BL/6 mice and showed that MAYV strain BeAr505411 induced robust tissue dissemination and disease. Three male rhesus macaques were subcutaneously challenged with 105 plaque-forming units of this strain into the arms. Peak plasma viremia occurred at 2 days post-infection (dpi). NHPs were taken to necropsy at 10 dpi to assess viral dissemination, which included the muscles and joints, lymphoid tissues, major organs, male reproductive tissues, as well as peripheral and central nervous system tissues. Histological examination demonstrated that MAYV infection was associated with appendicular joint and muscle inflammation as well as presence of perivascular inflammation in a wide variety of tissues. One animal developed a maculopapular rash and two NHP had viral RNA detected in upper torso skin samples, which was associated with the presence of perivascular and perifollicular lymphocytic aggregation. Analysis of longitudinal peripheral blood samples indicated a robust innate and adaptive immune activation, including the presence of anti-MAYV neutralizing antibodies with activity against related Una virus and chikungunya virus. Inflammatory cytokines and monocyte activation also peaked coincident with viremia, which was well supported by our transcriptomic analysis highlighting enrichment of interferon signaling and other antiviral processes at 2 days post MAYV infection. The rhesus macaque model of MAYV infection recapitulates many of the aspects of human infection and is poised to facilitate the evaluation of novel therapies and vaccines targeting this re-emerging virus.

A non-human primate model for human norovirus infection

Exposure Route Influences Disease Severity in the COVID-19 Cynomolgus Macaque Model

Human Norovirus: Experimental Models of Infection

Establishment of a Rhesus Macaque Model for Coxsackievirus A6 Infection: Pilot Study to Evaluate Infection Initiated Through the Respiratory or Digestive Track

Comparative Transcriptomic Response of Primary and Immortalized Macrophages to Murine Norovirus Infection

Norovirus immunology: Of mice and mechanisms

Infection of neonatal mice with the murine norovirus strain WU23 is a robust model to study norovirus pathogenesis

Norovirus-mediated translation repression promotes macrophage cell death

Experimental miniature piglet model for the infection of human norovirus GII

Neonatal rhesus monkey is a potential animal model for studying pathogenesis of EV71 infection.

Non-Human Primate Models of Enteric Viral Infections

Human norovirus targets enteroendocrine epithelial cells in the small intestine

Mayaro virus pathogenesis and immunity in rhesus macaques

Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice

Intra- and Inter-host Evolution of Human Norovirus in Healthy Adults

Enhanced Detection and Study of Murine Norovirus-1 Using a More Efficient Microglial Cell Line

Mucosal and systemic neutralizing antibodies to norovirus induced in infant mice orally inoculated with recombinant rotaviruses

Utilizing non-human primate models to combat recent COVID-19/SARS-CoV-2 and viral infectious disease outbreaks

Development of a Well-Characterized Cynomolgus Macaque Model of Marburg Virus Disease for Support of Vaccine and Therapy Development

Baboon model for West Nile virus infection and vaccine evaluation